Al Razi Medical Co. recorded a 74% drop in net profit to SAR 176,000 for 2024 from SAR 686,000 a year earlier.
Item | 2023 | 2024 | Change |
---|---|---|---|
Revenues | 61.33 | 61.35 | 0.0 % |
Gross Income | 17.58 | 16.59 | (5.7 %) |
Operating Income | 1.33 | 0.43 | (67.3 %) |
Net Income | 0.69 | 0.18 | (74.4 %) |
Average Shares | 1.52 | 1.52 | - |
Earnings Per Share before unusual items (Riyals) | 0.45 | 0.12 | (74.4 %) |
EPS (Riyal) | 0.45 | 0.12 | (74.4 %) |
The company invested in promotional offers to support sales of non-pharmaceutical products along with the increased selling and distribution expenses for new and growing branches to achieve sales targets.
However, Al Razi recorded a slight increase in revenue by SAR 17,588, or 0.028%, compared to 2023.
Item | H2 2023 | H2 2024 | Change |
---|---|---|---|
Revenues | 30.79 | 30.15 | (2.1 %) |
Gross Income | 8.43 | 8.40 | (0.4 %) |
Operating Income | 0.33 | 0.21 | (37.5 %) |
Net Income | 0.08 | 0.17 | 108.2 % |
Average Shares | 1.52 | 1.52 | - |
Earnings Per Share before unusual items (Riyal) | 0.05 | 0.11 | 108.2 % |
EPS (Riyal) | 0.05 | 0.11 | 108.2 % |
Item | H1 2024 | H2 2024 | Change |
---|---|---|---|
Revenues | 31.20 | 30.15 | (3.4 %) |
Gross Income | 8.19 | 8.40 | 2.7 % |
Operating Income | 0.23 | 0.21 | (9.4 %) |
Net Income | 0.01 | 0.17 | 1540.6 % |
Average Shares | 1.52 | 1.52 | - |
Earnings Per Share before unusual items (Riyal) | 0.01 | 0.11 | 1540.6 % |
EPS (Riyal) | 0.01 | 0.11 | 1540.6 % |
In H2 2024, the company’s net earnings more than doubled to SAR 166,000 from SAR 0.08 million in the second half of 2023.
On a half-on-half basis, net earnings skyrocketed from SAR 0.01 million in H1 2024.
Shareholders’ equity, no minority interest, rose to SAR 22.6 million as of Dec. 31, 2024, from SAR 22.4 million a year earlier.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: